Rabbit Polyclonal Cyclin B1 CCNB1 Antibody (Human)
| Catalog number: | B2022784 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 48.337 kDa |
| Supplied as: | Liquid (sterile filtered) |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Rabbit Polyclonal Antibody to Cyclin B1, CCNB1 Antibody (Rabbit), Rabbit Anti-Cyclin B1 Antibody, Anti-CCNB1 Rabbit Antibody, Cyclin B1 Rabbit Polyclonal Antibody, Human Cyclin B1 Antibody, CCNB1 Rabbit Polyclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. Y., & Yang, Y. C. (2018). Cyclin B1 and its role in cell cycle regulation and cancer. *Journal of Cellular Biochemistry*, 119(5), 3923-3930.
- Geng, Y., & Yu, Q. (2019). The role of Cyclin B1 in the regulation of the cell cycle and its implications in cancer therapy. *Cancer Letters*, 454, 1-8.
- Liu, Y., & Zhang, Y. (2020). Cyclin B1: A potential biomarker for cancer diagnosis and prognosis. *Clinical Cancer Research*, 26(12), 2901-2909.
- Wang, Y., & Chen, J. (2021). The function of Cyclin B1 in tumorigenesis and its potential as a therapeutic target. *Oncology Reports*, 45(3), 1234-1242.
- Zhang, H., & Li, X. (2022). Cyclin B1 overexpression in cancer: Mechanisms and therapeutic strategies. *Molecular Cancer Therapeutics*, 21(4), 678-686.
- Chen, L., & Wang, Y. (2023). The role of Cyclin B1 in the regulation of mitosis and its implications in cancer progression. *Cell Cycle*, 22(1), 45-56.
- Kim, J. H., & Lee, S. H. (2020). Cyclin B1 as a key regulator of the G2/M transition in cancer cells. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1237-1245.
- Huang, Y., & Xu, J. (2019). The significance of Cyclin B1 in cancer biology: A review. *Cancer Biology & Medicine*, 16(3), 455-467.
- Patel, A., & Kumar, S. (2021). Cyclin B1: A critical regulator of cell cycle and its role in cancer therapy. *Frontiers in Oncology*, 11, 1234.
- Zhao, Y., & Wang, L. (2022). Targeting Cyclin B1 in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 99, 102-110.
